Related Experiment Video
Updated: Jul 30, 2025

08:07
Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
Published on: April 28, 2023
1.6K
Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
Felipe J Renna1, Malena Herrera Lopez2, Maria Manifava3
1Instituto de Bioquimica y Medicina Molecular Prof Alberto Boveris (IBIMOL), Universidad de Buenos Aires, CONICET; fjrenna@ffyb.uba.ar.
Journal of Visualized Experiments : Jove
|May 15, 2023
Summary
Autophagy, a cellular recycling process, is highly active in pancreatic cancer cells. This study quanties autophagy levels in cancer cells versus normal cells to understand its role in cancer adaptation.
Area of Science:
- Cell Biology
- Cancer Research
- Biochemistry
Background:
- Autophagy is a critical cellular process for maintaining homeostasis by degrading damaged components.
- Cancer cells, particularly pancreatic cancer, exhibit elevated autophagy to survive stressful conditions like nutrient deprivation and chemotherapy.
- Understanding autophagy modulation in pancreatic cancer is crucial for developing targeted therapies.
Purpose of the Study:
- To quantify and compare autophagy levels in pancreatic cancer cells (PANC-1) and normal pancreatic acinar cells (AR42J).
- To establish a method for measuring autophagy activation using LC3 immunofluorescence and image analysis.
- To provide a basis for studying autophagy modulation under various stress conditions relevant to cancer.
Main Methods:
- Utilized immunofluorescence staining for microtubule-associated protein light chain 3 (LC3) to detect autophagosomes.
- Employed the PANC-1 cell line as a model for pancreatic cancer and AR42J for normal pancreatic cells.
- Quantified autophagic structures using the open-source FIJI software with the "3D Objects Counter" tool.
Main Results:
- Established a quantitative method to measure autophagy activation via LC3-II formation.
- Demonstrated differences in autophagy status between pancreatic cancer cells and normal pancreatic cells.
- The methodology allows for the assessment of autophagy under conditions like hypoxia or chemotherapy.
Conclusions:
- Pancreatic cancer cells exhibit distinct autophagy profiles compared to normal cells.
- The developed LC3-based method provides a reliable tool for autophagy research in pancreatic cancer.
- Further studies can leverage this method to explore therapeutic strategies targeting autophagy in pancreatic adenocarcinoma.

